Blood Glucose and Triglyceride Changes Following the Administration of Commercial Enteral Nutrition Solutions with Differing Glucose and Fat Contents

不同葡萄糖和脂肪含量的商业肠内营养液给药后血糖和甘油三酯的变化

阅读:1

Abstract

OBJECTIVE: To clarify whether reducing the energy ratio of carbohydrates and increasing the ratio of fats contribute to suppressing blood glucose elevation not only under normal conditions, but also under the effects of glucocorticoids. METHODOLOGY: Three test enteral nutrition solutions, differing in energy ratios and used in actual clinical settings, were given to rats: HINEX E-Gel (ST) with 20% fat and 64% carbohydrate content; HINEX E-Gel LC (LC) with 34% fat and 50% carbohydrate content; and HINEX Renute (RN) with 50% fat and 26% carbohydrate content. The time course data of plasma glucose, triglyceride, and insulin levels after a single oral administration of the test EN solution were obtained in normal rats (Experiment 1) and hyperglycemia model rats treated with dexamethasone (Experiment 2). RESULT: In both normal and dexamethasone-induced hyperglycemic rats, plasma glucose levels were lower in the groups given RN than in the groups given ST. The differences in EN solutions did not significantly affect plasma triglyceride and insulin levels in both rat models. CONCLUSION: This study suggested that the EN solution that is high in fat and low in carbohydrate suppressed the post-administration increase of blood glucose levels even in a state of steroid-induced hyperglycemia with insulin resistance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。